About Sequent Research Limited
Data last updated:
Sequent Research Limited was a public limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Sequent Scientific Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 13 April 2007.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TS2007PLC196886. Its GSTIN is 29AAKCS7538Q1Z8 (Karnataka).
The company had an authorised share capital of ₹4.7 Cr and a paid-up capital of ₹4.41 Cr. It was formerly known as Sequent Research Private Limited. It was led by directors including Prasad Sitaram Lad and Vedprakash Shantalingappa Ragate.
Its last annual general meeting (AGM) was held on 07 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.52 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net loss of ₹55.45 Lakh (net margin -5.8%) and EBITDA of ₹1.23 Cr (EBITDA margin 12.9%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.
The company had about 52 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: SeQuent. As per MCA filings, the company had satisfied charges of ₹32.85 Cr on record. The company has 1 deal on record (1 acquisition); the latest was in March 2010. The company has 3 MSME Form 1 returns on record between 2019 and 2022, listing 5 overdue payments to 4 micro and small suppliers.
The last known website on record is sequent.in.
Company details
CIN history
Sequent Research has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232TS2007PLC196886, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TS2007PLC196886 | Current |
| U24232KA2007PLC042483 | Previous |
| U24232KA2007PTC042483 | Previous |
Contact details
Sequent Research Limited's registered office is in Hyderabad, Telangana.
- Social Media
- Registered Address3rd Floor Srivallis Corporate Plot No. 290, Syn 33 34P To 39 Guttala Begumpet Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sequent Research operates one associated brand: SeQuent. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs are developed and manufactured for therapeutic areas. | sequent.in |
Business activity
The main business activity of Sequent Research is professional, scientific and technical. In detail, this covers architecture, engineering activities, technical testing and analysis activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities |
To see the full business activity and turnover split of Sequent Research Limited, buy the company report.
Financials of Sequent Research Limited
FY 2025 filings availableSequent Research Limited reported revenue of ₹9.52 Cr (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 4% fall in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹55.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | ||||
| Net Profit Margin | -5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sequent Research Limited, buy the company report.
Board of directors of Sequent Research Limited
Sequent Research has 4 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prasad Sitaram Lad | Director | 24 May 2022 | 4 Years 5 Months | As last reported |
| Vedprakash Shantalingappa Ragate | Director | 11 Apr 2024 | 2 Years 6 Months | As last reported |
| Saurav Bhala Also directs: Alivira Animal Health Limited | Director | 13 Feb 2024 | 2 Years 8 Months | As last reported |
| Rajaram Narayanan Also directs: Viyash Scientific Limited, Alivira Animal Health Limited | Director | 11 Apr 2022 | 4 Years 6 Months | As last reported |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jun 2015 | 10579263 | Others | ₹11.05 Cr | Satisfied | |
| 20 Dec 2012 | 10395150 | Housing Development Finance Corporation Limited | ₹12 Cr | Satisfied | |
| 24 Oct 2007 | 10073943 | Corporation Bank | ₹9.8 Cr | Satisfied |
To see the full charge records of Sequent Research Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Sequent Research Limited has 1 deal on record (1 acquisition); the latest was in March 2010.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2010 | Acquisition | ₹13 Cr | Buyer: Viyash Scientific Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Sequent Research Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Sequent Research Limited was last rated by Icra on 16 Aug 2018.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 16 Aug 2018 |
To see the full credit ratings and regulatory alerts of Sequent Research Limited, buy the company report.
MSME payment delays
Sequent Research Limited has 3 MSME Form 1 returns on record between 2019 and 2022, listing 5 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Malabar Oxygen Company Private Limited | |||
| Synthesis Solutions LLP | |||
| an individual supplier | |||
| Merieux Nutrisciences Bangalore Private Limited |
To see the full MSME payment records of Sequent Research Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Sequent Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAKCS7538Q1Z8 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sequent Research Limited, buy the company report.
Recent activity
Sequent Research Limited has 19 board changes on record since 2008: 4 appointments and 15 cessations. The latest: Saurav Bhala ceased to be Additional Director on 15 Sep 2024.
17 earlier events are in the company report.
News
Frequently asked questions
Sequent Research has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Sequent Research was a public limited company based in Hyderabad, Telangana, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 13 April 2007 and is registered under CIN U24232TS2007PLC196886. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Sequent Research was incorporated on 13 April 2007. It is registered with the Registrar of Companies, Hyderabad.
Sequent Research had 4 directors:
- Prasad Sitaram Lad - Director
- Vedprakash Shantalingappa Ragate - Director
- Saurav Bhala - Director
- Rajaram Narayanan - Director
The CIN (Corporate Identification Number) of Sequent Research is U24232TS2007PLC196886. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sequent Research is at 3rd Floor Srivallis Corporate Plot No. 290, Syn 33 34P To 39 Guttala Begumpet Jubilee Hills, Hyderabad, Telangana, India – 500033.
Sequent Research can be reached through the website sequent.in. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Sequent Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 07 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sequent Research is 29AAKCS7538Q1Z8, registered in Karnataka.
Sequent Research operated in the pharma industry, in the pharma contract r and d segment.
Sequent Research has 1 deal on record (1 acquisition); the latest was in March 2010.